TY - JOUR
T1 - A cross-population atlas of genetic associations for 220 human phenotypes
AU - FinnGen
AU - Sakaue, Saori
AU - Kanai, Masahiro
AU - Tanigawa, Yosuke
AU - Karjalainen, Juha
AU - Kurki, Mitja
AU - Koshiba, Seizo
AU - Narita, Akira
AU - Konuma, Takahiro
AU - Yamamoto, Kenichi
AU - Akiyama, Masato
AU - Ishigaki, Kazuyoshi
AU - Suzuki, Akari
AU - Suzuki, Ken
AU - Obara, Wataru
AU - Yamaji, Ken
AU - Takahashi, Kazuhisa
AU - Asai, Satoshi
AU - Takahashi, Yasuo
AU - Suzuki, Takao
AU - Shinozaki, Nobuaki
AU - Yamaguchi, Hiroki
AU - Minami, Shiro
AU - Murayama, Shigeo
AU - Yoshimori, Kozo
AU - Nagayama, Satoshi
AU - Obata, Daisuke
AU - Higashiyama, Masahiko
AU - Masumoto, Akihide
AU - Koretsune, Yukihiro
AU - Ito, Kaoru
AU - Terao, Chikashi
AU - Yamauchi, Toshimasa
AU - Komuro, Issei
AU - Kadowaki, Takashi
AU - Tamiya, Gen
AU - Yamamoto, Masayuki
AU - Nakamura, Yusuke
AU - Kubo, Michiaki
AU - Murakami, Yoshinori
AU - Yamamoto, Kazuhiko
AU - Kamatani, Yoichiro
AU - Palotie, Aarno
AU - Rivas, Manuel A.
AU - Daly, Mark J.
AU - Matsuda, Koichi
AU - Okada, Yukinori
N1 - Funding Information:
We thank all the participants of BioBank Japan, UK Biobank and FinnGen. We thank K. Watanabe for her input in the analysis of phenotypic correlations and pleiotropy. This research was supported by the Tailor-Made Medical Treatment program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Japan Agency for Medical Research and Development (AMED). The FinnGen project is funded by two grants from Business Finland (grant nos. HUS 4685/31/2016 and UH 4386/31/2016) and nine industry partners (AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GSK, MSD, Pfizer and Sanofi). The following biobanks are acknowledged for collecting the FinnGen project samples: Auria Biobank (https:// www.auria.fi/biopankki/), THL Biobank (https://thl.fi/fi/web/thl-biopank), Helsinki Biobank (https://www.terveyskyla.fi/helsinginbiopankki/), Northern Finland Biobank Borealis (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki), Finnish Clinical Biobank Tampere (https://www.tays.fi/biopankki), Biobank of Eastern Finland (https:// ita-suomenbiopankki.fi), Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/ Biopankki), Finnish Red Cross Blood Service Biobank (https://www.bloodservice.fi/ Research%20Projects/biobanking) and Terveystalo Biobank Finland (https://www. terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/). S.S. was in part supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders and the JCR Grant for Promoting Basic Rheumatology. M. Kanai was supported by a Nakajima Foundation Fellowship and the Masason Foundation. Y. Tanigawa is in part supported by a Funai Overseas Scholarship from the Funai Foundation for Information Technology and the Stanford University School of Medicine. M.A.R. is in part supported by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) under award no. R01HG010140, and an NIH Center for Multi-and Cross-population Mapping of Mendelian and Complex Diseases grant (no. 5U01 HG009080). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Y.O. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant nos. 19H01021, 20K21834) and AMED (grant nos. JP21km0405211, JP21ek0109413, JP21ek0410075, JP21gm4010006 and JP21km0405217), JST Moonshot R&D Grant Number JPMJMS2021, Takeda Science Foundation and the Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2021/10
Y1 - 2021/10
N2 - Current genome-wide association studies do not yet capture sufficient diversity in populations and scope of phenotypes. To expand an atlas of genetic associations in non-European populations, we conducted 220 deep-phenotype genome-wide association studies (diseases, biomarkers and medication usage) in BioBank Japan (n = 179,000), by incorporating past medical history and text-mining of electronic medical records. Meta-analyses with the UK Biobank and FinnGen (ntotal = 628,000) identified ~5,000 new loci, which improved the resolution of the genomic map of human traits. This atlas elucidated the landscape of pleiotropy as represented by the major histocompatibility complex locus, where we conducted HLA fine-mapping. Finally, we performed statistical decomposition of matrices of phenome-wide summary statistics, and identified latent genetic components, which pinpointed responsible variants and biological mechanisms underlying current disease classifications across populations. The decomposed components enabled genetically informed subtyping of similar diseases (for example, allergic diseases). Our study suggests a potential avenue for hypothesis-free re-investigation of human diseases through genetics.
AB - Current genome-wide association studies do not yet capture sufficient diversity in populations and scope of phenotypes. To expand an atlas of genetic associations in non-European populations, we conducted 220 deep-phenotype genome-wide association studies (diseases, biomarkers and medication usage) in BioBank Japan (n = 179,000), by incorporating past medical history and text-mining of electronic medical records. Meta-analyses with the UK Biobank and FinnGen (ntotal = 628,000) identified ~5,000 new loci, which improved the resolution of the genomic map of human traits. This atlas elucidated the landscape of pleiotropy as represented by the major histocompatibility complex locus, where we conducted HLA fine-mapping. Finally, we performed statistical decomposition of matrices of phenome-wide summary statistics, and identified latent genetic components, which pinpointed responsible variants and biological mechanisms underlying current disease classifications across populations. The decomposed components enabled genetically informed subtyping of similar diseases (for example, allergic diseases). Our study suggests a potential avenue for hypothesis-free re-investigation of human diseases through genetics.
UR - http://www.scopus.com/inward/record.url?scp=85116399963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116399963&partnerID=8YFLogxK
U2 - 10.1038/s41588-021-00931-x
DO - 10.1038/s41588-021-00931-x
M3 - Article
C2 - 34594039
AN - SCOPUS:85116399963
SN - 1061-4036
VL - 53
SP - 1415
EP - 1424
JO - Nature genetics
JF - Nature genetics
IS - 10
ER -